Search Results

Structure Activity Relationship of Organic Alcohol and Esters for Antidepressant- Like Activity

Authors: Perveen, Shahnaz; Yasmeen, Arfa; Khan, Muhammad A.; Dar, Ahsana; Jafri, Rehana; Ahmed, Amir

Source: Letters in Drug Design & Discovery, Volume 7, Number 1, January 2010 , pp. 14-17(4)

Publisher: Bentham Science Publishers

Other Drugs Acting on Nervous System Associated with QT-Interval Prolongation

Authors: Keller, Guillermo A.; Ponte, Marcelo L.; Di Girolamo, Guillermo

Source: Current Drug Safety, Volume 5, Number 1, January 2010 , pp. 105-111(7)

Publisher: Bentham Science Publishers

Proarrhythmic Risk with Antipsychotic and Antidepressant Drugs: Implications in the Elderly

Authors: Vieweg, W. Victor R.; Wood, Mark A.; Fernandez, Antony; Beatty-Brooks, Mary; Hasnain, Mehrul; Pandurangi, Anand K.

Source: Drugs & Aging, Volume 26, Number 12, 1 December 2009 , pp. 997-1012(16)

Publisher: Adis International

Clinical utility of Patient Health Questionnaire-9 (PHQ-9) in memory clinics

Authors: Hancock, P.; Larner, A. J.

Source: International Journal of Psychiatry in Clinical Practice, Volume 13, Number 3, September 2009 , pp. 188-191(4)

Publisher: Informa Healthcare

Pharmacotherapy of postpartum depression

Authors: di Scalea, Teresa Lanza; Wisner, Katherine L

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 16, November 2009 , pp. 2593-2607(15)

Publisher: Informa Healthcare

Mecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders

Authors: Bacher, Ingrid; Wu, Becky; Shytle, Douglas R; George, Tony P

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 16, November 2009 , pp. 2709-2721(13)

Publisher: Informa Healthcare

Sex Hormones and Mood in the Perimenopause

Authors: Schmidt, Peter J.; Rubinow, David R.

Source: Annals of the New York Academy of Sciences, Volume 1179, Number 1, October 2009 , pp. 70-85(16)

Publisher: Blackwell Publishing

Role of CRF Receptor Signaling in Stress Vulnerability, Anxiety, and Depression

Authors: Hauger, Richard L.; Risbrough, Victoria; Oakley, Robert H.; Olivares-Reyes, J. Alberto; Dautzenberg, Frank M.

Source: Annals of the New York Academy of Sciences, Volume 1179, Number 1, October 2009 , pp. 120-143(24)

Publisher: Blackwell Publishing

Risk Factors for Development of Depression and Psychosis: Glucocorticoid Receptors and Pituitary Implications for Treatment with Antidepressant and Glucocorticoids

Author: Pariante, Carmine M.

Source: Annals of the New York Academy of Sciences, Volume 1179, Number 1, October 2009 , pp. 144-152(9)

Publisher: Blackwell Publishing

The Course of Adverse Effects of Nortriptyline and Venlafaxine in Elderly Patients with Major Depression

Authors: Kok, Rob M.; Aartsen, Marja; Nolen, Willem A.; Heeren, Thea J.

Source: Journal of the American Geriatrics Society, Volume 57, Number 11, November 2009 , pp. 2112-2117(6)

Publisher: Blackwell Publishing

What is the association between depression and Alzheimer's disease?

Authors: Tsuno, Norifumi; Homma, Akira

Source: Expert Review of Neurotherapeutics, Volume 9, Number 11, November 2009 , pp. 1667-1676(10)

Publisher: Expert Reviews

Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect

Authors: Mann, Liad; Heldman, Eliahu; Bersudsky, Yuly; Vatner, Stephen F; Ishikawa, Yoshihiro; Almog, Orna; Belmaker, Robert H; Agam, Galila

Source: Bipolar Disorders, Volume 11, Number 8, December 2009 , pp. 885-896(12)

Publisher: Blackwell Publishing

Evaluation of anti-obesity activity of duloxetine in comparison with sibutramine along with its anti-depressant activity: an experimental study in obese rats

Authors: Chudasama, H.P.; Bhatt, P.A.

Source: Canadian Journal of Physiology and Pharmacology, Volume 87, Number 11, 1 November 2009 , pp. 900-907(8)

Publisher: NRC Research Press

The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum

Authors: Sarris, J.; Kavanagh, D.; Byrne, G.; Bone, K.; Adams, J.; Deed, G.

Source: Psychopharmacology, Volume 205, Number 3, August 2009 , pp. 399-407(9)

Publisher: Springer

Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response

Authors: Min, Wenjiao; Li, Tao; Ma, Xiaohong; Li, Zhengyu; Yu, Tao; Gao, Dong; Zhang, Bo; Yun, Yang; Sun, Xueli

Source: Psychopharmacology, Volume 205, Number 3, August 2009 , pp. 409-417(9)

Publisher: Springer

Chronic oral nicotine increases brain [³H]epibatidine binding and responsiveness to antidepressant drugs, but not nicotine, in the mouse forced swim test

Authors: Andreasen, Jesper; Nielsen, Elsebet; Redrobe, John

Source: Psychopharmacology, Volume 205, Number 3, August 2009 , pp. 517-528(12)

Publisher: Springer

Antidepressants for neuroenhancement in healthy individuals: a systematic review

Authors: Repantis, Dimitris; Schlattmann, Peter; Laisney, Oona; Heuser, Isabella

Source: Poiesis & Praxis, Volume 6, Numbers 3-4, August 2009 , pp. 139-174(36)

Publisher: Springer

Subway Train-Related Fatalities in New York City: Accident versus Suicide

Authors: Lin, Peter T.; Gill, James R.

Source: Journal of Forensic Sciences, Volume 54, Number 6, November 2009 , pp. 1414-1418(5)

Publisher: Blackwell Publishing

Photochemical Reactions Involved in the Phototoxicity of the Anticonvulsant and Antidepressant Drug Lamotrigine (Lamictal^®)

Authors: Bilski, Piotr J.; Wolak, M. A.; Zhang, V.; Moore, D. E.; Chignell, C. F.

Source: Photochemistry and Photobiology, Volume 85, Number 6, November/December 2009 , pp. 1327-1335(9)

Publisher: Blackwell Publishing

Editorial [Hot topic: Aiming at New Targets for the Treatment of Affective Disorders (Guest Editor: Eliyahu Dremencov)]

Author: Dremencov, Eliyahu

Source: Current Drug Targets, Volume 10, Number 11, November 2009 , pp. 1049-1049(1)

Publisher: Bentham Science Publishers